
News|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products
The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.
Advertisement
Articles in this issue
almost 21 years ago
Correcting the Coursealmost 21 years ago
February 2005almost 21 years ago
Good Work and True: USP Prepares for Convention 2005almost 21 years ago
Contract Manufacturers Getting Squeezedalmost 21 years ago
In the Spotlight-February 2005almost 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Linealmost 21 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dalmost 21 years ago
In Defense of USP Singlet TestingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Trends and Challenges Impacting Highly Potent API Development
2
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
3
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
4
How Innovation and Risk Management Are Reshaping Modern Drug Manufacturing
5





